http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Myriad, AstraZeneca and Merck Expand Companion Diagnostic Partnership
-
Myriad, AstraZeneca and Merck Expand Companion Diagnostic Partnership
-
Myriad Women’s Health to Highlight New Studies Demonstrating the Superior Clinical Performance of the Foresight® and Prequel™ Prenatal Tests
-
Myriad Women’s Health to Highlight New Studies Demonstrating the Superior Clinical Performance of the Foresight® and Prequel™ Prenatal Tests
-
Myriad to Present 18 Studies at the 2019 Annual Clinical Genetics Meeting
-
Myriad to Present 18 Studies at the 2019 Annual Clinical Genetics Meeting
-
Myriad Genetics (MYGN) Says myPath Melanoma Test Receives Medicare Coverage
-
Myriad’s myPath® Melanoma Test Receives Medicare Coverage
-
Myriad’s myPath® Melanoma Test Receives Medicare Coverage
-
Myriad Genetics (MYGN) Reports Publication of Clinical Studies for Vectra Showing Better Prediction Results for Radiographic Progression in People with RA
-
Vectra® Study Published in the Journal Current Medical Research & Opinion
-
Vectra® Study Published in the Journal Current Medical Research & Opinion
-
Myriad Applauds the American Society of Breast Surgeons New Guidelines Recommending Genetic Testing for All People with Breast Cancer
-
Myriad Applauds the American Society of Breast Surgeons New Guidelines Recommending Genetic Testing for All People with Breast Cancer
-
Myriad to Present New Data for Its Expanded Carrier and Noninvasive Prenatal Screens at the 2019 Society for Maternal-Fetal Medicine Annual Meeting
-
Myriad to Present New Data for Its Expanded Carrier and Noninvasive Prenatal Screens at the 2019 Society for Maternal-Fetal Medicine Annual Meeting
-
Myriad Genetics (MYGN) Reports Publication of GUIDED Study in Journal of Psychiatric Research
-
GeneSight® GUIDED Study Published in the Journal of Psychiatric Research
-
GeneSight® GUIDED Study Published in the Journal of Psychiatric Research
-
Myriad Announces Important New Data for Its EndoPredict® Breast Cancer Test Will Be Presented at the 2018 San Antonio Breast Cancer Symposium
-
Myriad Announces Important New Data for Its EndoPredict® Breast Cancer Test Will Be Presented at the 2018 San Antonio Breast Cancer Symposium
-
Myriad Validates Polygenic Score to Predict Breast Cancer Risk in Women of Hispanic Ancestry Who Test Negative for Hereditary Cancer Mutations
-
Myriad Validates Polygenic Score to Predict Breast Cancer Risk in Women of Hispanic Ancestry Who Test Negative for Hereditary Cancer Mutations
-
Myriad Genetics (MYGN) Announces Accelerated $50M Share Buyback Plan
-
Myriad Announces $50 Million Accelerated Share Repurchase Program
-
Myriad Announces $50 Million Accelerated Share Repurchase Program
-
Myriad to Present New Data from Its Industry-Leading Portfolio of Genetic Tests for Breast Cancer at the 2018 San Antonio Breast Cancer Symposium
-
Myriad to Present New Data from Its Industry-Leading Portfolio of Genetic Tests for Breast Cancer at the 2018 San Antonio Breast Cancer Symposium
-
Myriad Receives the Prestigious 2018 Utah Top Workplaces Award
-
Myriad Receives the Prestigious 2018 Utah Top Workplaces Award
-
Myriad Presents Two New Studies at the Western Section of the American Urological Association
-
Myriad Presents Two New Studies at the Western Section of the American Urological Association
-
Myriad Genetics (MYGN) Reports New Data on Two Studies of Vectra Test in Patients with RA Treated with Tofacitinib & Rituximab
-
New Studies Highlight Performance of Vectra® Test in Patients with Rheumatoid Arthritis Who Were Treated with Tofacitinib and Rituximab
-
New Studies Highlight Performance of Vectra® Test in Patients with Rheumatoid Arthritis Who Were Treated with Tofacitinib and Rituximab
-
Crescendo Bioscience Announces Four Studies with Vectra® DA Will Be Featured at the 2018 European League Against Rheumatism Annual Meeting
-
Crescendo Bioscience Announces Four Studies with Vectra® DA Will Be Featured at the 2018 European League Against Rheumatism Annual Meeting
-
Myriad Genetics (MYGN) Highlights Second Pivotal Validation Study for riskScore Test at 2018 ASCO Meetings
-
Myriad Genetics Presents Second Pivotal Validation Study for riskScore™ Test at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
-
Myriad Genetics Presents Second Pivotal Validation Study for riskScore™ Test at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
-
GeneSight® Guided Treatment Significantly Improves Outcomes for Patients with Major Depression Treated in the Primary Care Setting
-
GeneSight® Guided Treatment Significantly Improves Outcomes for Patients with Major Depression Treated in the Primary Care Setting
-
Myriad Genetics to Present Eight Studies at the 2018 American Society of Clinical Oncology Annual Meeting
-
Myriad Genetics to Present Eight Studies at the 2018 American Society of Clinical Oncology Annual Meeting
-
Landmark Study Shows GeneSight® Test Led to Significant Improvement in Mental Health Outcomes for Patients with Major Depressive Disorder
-
Landmark Study Shows GeneSight® Test Led to Significant Improvement in Mental Health Outcomes for Patients with Major Depressive Disorder
-
Myriad Genetics to Present Five Studies at the Seventh International Symposium on Hereditary Breast and Ovarian Cancer
-
Myriad Genetics to Present Five Studies at the Seventh International Symposium on Hereditary Breast and Ovarian Cancer
-
Myriad Genetics Named to Forbes 2018 List of America’s Best Midsize Employers
-
Myriad Genetics Named to Forbes 2018 List of America’s Best Midsize Employers
